FDA-cleared profile

LVivo Software Application

DiA Imaging Analysis Ltd. · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Automated echo DICOM LV and RV function and contrast-EF, strain, wall-motion, bladder-volume and quality-score support.

Clinical role
Automated quantitative analysis and quality support for professional echocardiography interpretation; outputs require clinician review.
Images and patients
Ultrasound · Heart/Cardiovascular
Key limitation
Keep in mind: The exact validation used 101 examinations and a reference standard from three sonographers; contrast analysis depends on a prescribed contrast agent and suitable ultrasound equipment. Family LVivo support constraints are not promoted as exact K243235 labeling.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Automated echo DICOM LV and RV function and contrast-EF, strain, wall-motion, bladder-volume and quality-score support.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart/Cardiovascular Input: Echocardiography DICOM studies and supported 4-chamber, 2-chamber and 3-chamber views, including contrast-enhanced input where the CE-EF extension is prescribed and supported.
  • Who uses it?Intended users: Healthcare professionals interpreting echocardiography examinations.
  • What does the software produce?Output: Global and segmental LV ejection fraction, LV and RV function, wall-motion and strain measures, contrast-EF analysis, bladder volume and image-quality score outputs for review.
  • What is its most important limitation?Key limitation: The exact validation used 101 examinations and a reference standard from three sonographers; contrast analysis depends on a prescribed contrast agent and suitable ultrasound equipment. Family LVivo support constraints are not promoted as exact K243235 labeling.

Clinical takeaway. Clinical role: Automated echo DICOM LV and RV function and contrast-EF, strain, wall-motion, bladder-volume and quality-score support.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA performance set included 101 examinations and 91 successfully auto-processed examinations; reported correlations included 4-chamber EDV 0.96, 4-chamber ESV 0.98 and 4-chamber EF 0.95 against the reference measurements.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Automated echo DICOM LV and RV function and contrast-EF, strain, wall-motion, bladder-volume and quality-score support.
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Automated quantitative analysis and quality support for professional echocardiography interpretation; outputs require clinician review.
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Echocardiography DICOM studies and supported 4-chamber, 2-chamber and 3-chamber views, including contrast-enhanced input where the CE-EF extension is prescribed and supported.
  • Exact FDA submission
  • Checked 2026-09-06
Output and clinician action
Global and segmental LV ejection fraction, LV and RV function, wall-motion and strain measures, contrast-EF analysis, bladder volume and image-quality score outputs for review.
  • Exact FDA submission
  • Checked 2026-09-06
Care setting
Echocardiography services using DICOM studies and clinician review.
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Healthcare professionals interpreting echocardiography examinations.
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
The exact validation used 101 examinations and a reference standard from three sonographers; contrast analysis depends on a prescribed contrast agent and suitable ultrasound equipment. Family LVivo support constraints are not promoted as exact K243235 labeling.
  • Exact FDA submission
  • Checked 2026-09-06
Evidence summary
The exact FDA performance set included 101 examinations and 91 successfully auto-processed examinations; reported correlations included 4-chamber EDV 0.96, 4-chamber ESV 0.98 and 4-chamber EF 0.95 against the reference measurements.
  • Exact FDA submission
  • Checked 2026-09-06

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA performance set included 101 examinations and 91 successfully auto-processed examinations; reported correlations included 4-chamber EDV 0.96, 4-chamber ESV 0.98 and 4-chamber EF 0.95 against the reference measurements.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

4-chamber end-diastolic volume correlation

0.96 correlation

  • EndpointAutomated versus reference EDV
  • Population101 echocardiography examinations in the exact validation set
  • Tested versionLVivo Software Application release reviewed in K243235

4-chamber end-systolic volume correlation

0.98 correlation

  • EndpointAutomated versus reference ESV
  • Population101 echocardiography examinations in the exact validation set
  • Tested versionLVivo Software Application release reviewed in K243235

4-chamber ejection fraction correlation

0.95 correlation

  • EndpointAutomated versus reference EF
  • Population101 echocardiography examinations in the exact validation set
  • Tested versionLVivo Software Application release reviewed in K243235

LVivo Software Application LV measurement validation

  • DesignRetrospective clinical validation against three sonographer reference readers
  • PopulationEchocardiography examinations with supported LV views and measurements
  • Scopeexact submission
  • Tested versionLVivo Software Application release reviewed in K243235
  • Samplen=101
  • IndependenceSponsor or vendor study

K243235 FDA 510(k) summary

The FDA summary reports 91 of 101 examinations auto-processed and provides correlations for chamber-specific and biplane measurements.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Echocardiography DICOM studies and supported 4-chamber, 2-chamber and 3-chamber views, including contrast-enhanced input where the CE-EF extension is prescribed and supported.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243235

  2. Routing

    Source context, not route validation: The GE LVivo family support article describes clinician acceptance and storage of calculated measurements, while a historical Konica Minolta and DiA release describes LVivo family analysis and reporting on Exa Cardio PACS. These sources do not establish the exact K243235 interfaces.

    Scope: Product family.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · LVivo EF App support article · Konica Minolta and DiA expand AI-based echocardiography analysis and reporting on Exa Cardio PACS

  3. AI processing

    Source context, not route validation: The exact FDA materials describe processing echo DICOM studies in a clinical software workflow and returning measurements for clinician review.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243235

  4. Returned objects

    Source context, not route validation: Global and segmental LV ejection fraction, LV and RV function, wall-motion and strain measures, contrast-EF analysis, bladder volume and image-quality score outputs for review.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243235

  5. Viewer/worklist/report

    Unresolved route: Global and segmental LV ejection fraction, LV and RV function, wall-motion and strain measures, contrast-EF analysis, bladder volume and image-quality score outputs for review.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-06 · FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243235

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA materials describe processing echo DICOM studies in a clinical software workflow and returning measurements for clinician review.
  • Exact FDA submission
  • Checked 2026-09-06
Integration
The GE LVivo family support article describes clinician acceptance and storage of calculated measurements, while a historical Konica Minolta and DiA release describes LVivo family analysis and reporting on Exa Cardio PACS. These sources do not establish the exact K243235 interfaces.
  • Product family
  • Checked 2026-09-07

Echo DICOM analysis

The exact labeling describes automated analysis of echo DICOM views and return of quantitative outputs for clinician review.

exact submission · checked 2026-09-06

PACS family workflow

Historical partner documentation describes LVivo family analysis and reporting on Exa Cardio PACS; exact K243235 deployment is not established.

product family · checked 2026-09-07

Clinician result review

The GE family support article describes reviewing, accepting and storing calculated EF outputs; it is older family documentation and not an exact K243235 interface specification.

product family · checked 2026-09-07
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K243235
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-03-03
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
21Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The stored candidate metadata contained empty PubMed and clinical-trial ID arrays; metadata was screened, not full-text or registry-reviewed. The stored recall candidate record was empty and no event was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor manual, vendor press release, peer reviewed publication, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission

    No numeric price was published in the reviewed sources.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "LVivo DiA Imaging reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-07 - Exact FDA submission

    No current exact-release security attestation was established.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

9 sources - 3 history items

Source ledger

  1. K243235 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. LVivo Software Application model card (K243235)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

    Scope: intendedUsers, output, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. LVivo EF App support article

    GE HealthCare - Accessed 2026-09-07

    Scope: product_family, clinical_workflow, outputs, limitations

  8. Konica Minolta and DiA expand AI-based echocardiography analysis and reporting on Exa Cardio PACS

    Konica Minolta Healthcare Americas and DiA Imaging Analysis - Published 2020-11-10 - Accessed 2026-09-07

    Scope: product_family, PACS_integration, workflow

  9. FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243235

    U.S. Food and Drug Administration - Published 2025-03-03 - Accessed 2026-09-06

    Scope: identity, intended_use, performance, limitations, implementation

Research history

  1. K243235 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260780

HeartFocus

Deski

Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-06-03
FDA-cleared K253535

Ligence Heart

Ligence Uab

Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-02-27
FDA-cleared K252235

PVAD IQ Software

Ultrasight, Ltd.

Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2025-12-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history